Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

A model for streamlining psychotherapy in the RDoC era: the example of ‘Engage’

Abstract

A critical task for psychotherapy research is to create treatments that can be used by community clinicians. Streamlining of psychotherapies is a necessary first step for this purpose. We suggest that neurobiological knowledge has reached the point of providing biologically meaningful behavioral targets, thus guiding the development of effective, simplified psychotherapies. This view is supported by the Research Domain Criteria (RDoC) Project, which reflects the field’s consensus and recognizes the readiness of neurobiology to guide research in treatment development. ‘Engage’ is an example of such a streamlined therapy. It targets behavioral domains of late-life depression grounded on RDoC constructs using efficacious behavioral strategies selected for their simplicity. ‘Reward exposure’ targeting the behavioral expression of positive valence systems’ dysfunction is the principal therapeutic vehicle of ‘Engage’. Its first three sessions consist of direct ‘reward exposure’, but the therapists search for barriers in three behavioral domains, that is, ‘negativity bias’ (negative valence), ‘apathy’ (arousal) and ‘emotional dysregulation’ (cognitive control), and add strategies targeting these domains when needed. The end result is a structured, stepped approach using neurobiological constructs as targets and as a guide to personalization. We argue that the ‘reduction’ process needed in order to arrive to simplified effective therapies can be achieved in three steps: (1) identify RDoC constructs driving the syndrome’s psychopathology; (2) create a structured intervention utilizing behavioral and ecosystem modification techniques targeting behaviors related to these constructs; (3) examine whether the efficacy of the new intervention is mediated by change in behaviors related to the targeted RDoC constructs.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Thornicroft G . Evidence-based mental health care and implementation science in low- and middle-income countries. Epidemiol Psychiatr Sci 2012; 21: 241–244.

    Article  CAS  PubMed  Google Scholar 

  2. Chambers DA . Advancing the science of implementation: a workshop summary. Adm Policy Ment Health 2008; 35: 3–10.

    Article  PubMed  Google Scholar 

  3. Stahmer AC, Aarons G . Attitudes toward adoption of evidence-based practices: a comparison of autism early intervention providers and children’s mental health providers. Psychol Serv 2009; 6: 223–234.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Goldman HH, Azrin ST . Public policy and evidence-based practice. Psychiatr Clin N Am 2003; 26: 899–917.

    Article  Google Scholar 

  5. Gehart D . The core competencies and MFT education: practical aspects of transitioning to a learning-centered, outcome-based pedagogy. J Marital Fam Ther 2011; 37: 344–354.

    Article  PubMed  Google Scholar 

  6. Sburlati ES, Schniering CA, Lyneham HJ, Rapee RM . A model of therapist competencies for the empirically supported cognitive behavioral treatment of child and adolescent anxiety and depressive disorders. Clin Child Fam Psychol Rev 2011; 14: 89–109.

    Article  PubMed  Google Scholar 

  7. Spruill J, Rozensky RH, Stigall TT, Vasquez M, Bingham RP, De Vaney Olvey C . Becoming a competent clinician: basic competencies in intervention. J Clin Psychol 2004; 60: 741–754.

    Article  PubMed  Google Scholar 

  8. Mellman LA, Beresin E . Psychotherapy competencies: development and implementation. Acad Psychiatry 2003; 27: 149–153.

    Article  PubMed  Google Scholar 

  9. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010; 167: 748–751.

    Article  PubMed  Google Scholar 

  10. Cuthbert BN, Insel TR . Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 2013; 11: 126.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Russo SJ, Nestler EJ . The brain reward circuitry in mood disorders. Nat Rev Neurosci 2013; 14: 609–625.

    Article  CAS  PubMed  Google Scholar 

  12. Guo M, Lu Y, Garza JC, Li Y, Chua SC, Zhang W et al. Forebrain glutamatergic neurons mediate leptin action on depression-like behaviors and synaptic depression. Transl Psychiatry 2012; 2: e83.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Tye KM, Mirzabekov JJ, Warden MR, Ferenczi EA, Tsai HC, Finkelstein J et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 2013; 493: 537–541.

    Article  CAS  PubMed  Google Scholar 

  14. Warner-Schmidt JL, Schmidt EF, Marshall JJ, Rubin AJ, Arango-Lievano M, Kaplitt MG et al. Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior. Proc Natl Acad Sci USA 2012; 109: 11360–11365.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Sun H, Kennedy PJ, Nestler EJ . Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacology 2013; 38: 124–137.

    Article  CAS  PubMed  Google Scholar 

  16. Vialou V, Robison AJ, Laplant QC, Covington HE 3rd, Dietz DM, Ohnishi YN et al. DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat Neurosci 2010; 13: 745–752.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Blendy JA . The role of CREB in depression and antidepressant treatment. Biol Psychiatry 2006; 59: 1144–1150.

    Article  CAS  PubMed  Google Scholar 

  18. Koo JW, Russo SJ, Ferguson D, Nestler EJ, Duman RS . Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proc Natl Acad Sci USA 2010; 107: 2669–2674.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Takahashi T, Oono H, Inoue T, Boku S, Kako Y, Kitaichi Y et al. Depressive patients are more impulsive and inconsistent in intertemporal choice behavior for monetary gain and loss than healthy subjects—an analysis based on Tsallis’ statistics. Neuroendocrinol Lett 2008; 29: 351–358.

    PubMed  Google Scholar 

  20. Kunisato Y, Okamoto Y, Ueda K, Onoda K, Okada G, Yoshimura S et al. Effects of depression on reward-based decision making and variability of action in probabilistic learning. J Behav Ther Exp Psychiatry 2012; 43: 1088–1094.

    Article  PubMed  Google Scholar 

  21. Pizzagalli DA, Holmes AJ, Dillon DG, Goetz EL, Birk JL, Bogdan R et al. Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder. Am J Psychiatry 2009; 166: 702–710.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Robinson OJ, Cools R, Carlisi CO, Sahakian BJ, Drevets WC . Ventral striatum response during reward and punishment reversal learning in unmedicated major depressive disorder. Am J Psychiatry 2012; 169: 152–159.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Wacker J, Dillon DG, Pizzagalli DA . The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques. NeuroImage 2009; 46: 327–337.

    Article  PubMed  Google Scholar 

  24. Eppinger B, Hammerer D, Li SC . Neuromodulation of reward-based learning and decision making in human aging. Ann NY Acad Sci 2011; 1235: 1–17.

    Article  PubMed  Google Scholar 

  25. Dombrovski AY, Siegle GJ, Szanto K, Clark L, Reynolds CF, Aizenstein H . The temptation of suicide: striatal gray matter, discounting of delayed rewards, and suicide attempts in late-life depression. Psychol Med 2012; 42: 1203–1215.

    Article  CAS  PubMed  Google Scholar 

  26. Gawrysiak MJ, Carvalho JP, Rogers BP, Nicholas CR, Dougherty JH, Hopko DR . Neural changes following behavioral activation for a depressed breast cancer patient: a functional MRI case study. Case Rep Psychiatry 2012; 2012: 152916.

    PubMed  PubMed Central  Google Scholar 

  27. Dirmaier J, Steinmann M, Krattenmacher T, Watzke B, Barghaan D, Koch U et al. Non-pharmacological treatment of depressive disorders: a review of evidence-based treatment options. Rev Recent Clin Trials 2012; 7: 141–149.

    Article  CAS  PubMed  Google Scholar 

  28. Hunnicutt-Ferguson K, Hoxha D, Gollan J . Exploring sudden gains in behavioral activation therapy for major depressive disorder. Behav Res Ther 2012; 50: 223–230.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Moss K, Scogin F, Di Napoli E, Presnell A . A self-help behavioral activation treatment for geriatric depressive symptoms. Aging Ment Health 2012; 16: 625–635.

    Article  PubMed  Google Scholar 

  30. Unutzer J, Katon W, Williams JW Jr., Callahan CM, Harpole L, Hunkeler EM et al. Improving primary care for depression in late life: the design of a multicenter randomized trial. Med Care 2001; 39: 785–799.

    Article  CAS  PubMed  Google Scholar 

  31. Riebe G, Fan MY, Unutzer J, Vannoy S . Activity scheduling as a core component of effective care management for late-life depression. Int J Geriatr Psychiatry 2012; 27: 1298–1304.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Beck AT . The evolution of the cognitive model of depression and its neurobiological correlates. Am J Psychiatry 2008; 165: 969–977.

    Article  PubMed  Google Scholar 

  33. Gordon E, Barnett KJ, Cooper NJ, Tran N, Williams LM . An ‘integrative neuroscience’ platform: application to profiles of negativity and positivity bias. J Integr Neurosci 2008; 7: 345–366.

    Article  PubMed  Google Scholar 

  34. Williams LM, Gatt JM, Grieve SM, Dobson-Stone C, Paul RH, Gordon E et al. COMT Val(108/158)Met polymorphism effects on emotional brain function and negativity bias. NeuroImage 2010; 53: 918–925.

    Article  CAS  PubMed  Google Scholar 

  35. Williams LM, Gatt JM, Schofield PR, Olivieri G, Peduto A, Gordon E . 'Negativity bias' in risk for depression and anxiety: brain–body fear circuitry correlates, 5-HTT-LPR and early life stress. NeuroImage 2009; 47: 804–814.

    Article  CAS  PubMed  Google Scholar 

  36. Munafo MR, Brown SM, Hariri AR . Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry 2008; 63: 852–857.

    Article  CAS  PubMed  Google Scholar 

  37. Dannlowski U, Ohrmann P, Bauer J, Kugel H, Arolt V, Heindel W et al. Amygdala reactivity to masked negative faces is associated with automatic judgmental bias in major depression: a 3T fMRI study. J Psychiatry Neurosci 2007; 32: 423–429.

    PubMed  PubMed Central  Google Scholar 

  38. Monk CS, Klein RG, Telzer EH, Schroth EA, Mannuzza S, Moulton JL 3rd et al. Amygdala and nucleus accumbens activation to emotional facial expressions in children and adolescents at risk for major depression. Am J Psychiatry 2008; 165: 90–98.

    Article  PubMed  Google Scholar 

  39. Marin RS . Differential diagnosis and classification of apathy. Am J Psychiatry 1990; 147: 22–30.

    Article  CAS  PubMed  Google Scholar 

  40. Marin RS, Biedrzycki RC, Firinciogullari S . Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 1991; 38: 143–162.

    Article  CAS  PubMed  Google Scholar 

  41. Marin RS, Firinciogullari S, Biedrzycki RC . The sources of convergence between measures of apathy and depression. J Affect Disord 1993; 28: 7–14.

    Article  CAS  PubMed  Google Scholar 

  42. Mehta M, Whyte E, Lenze E, Hardy S, Roumani Y, Subashan P et al. Depressive symptoms in late life: associations with apathy, resilience and disability vary between young–old and old–old. Int J Geriatr Psychiatry 2008; 23: 238–243.

    Article  PubMed  Google Scholar 

  43. Forsell Y, Jorm AF, Fratiglioni L, Grut M, Winblad B . Application of DSM-III-R criteria for major depressive episode to elderly subjects with and without dementia. Am J Psychiatry 1993; 150: 1199–1202.

    Article  CAS  PubMed  Google Scholar 

  44. Lampe IK, Heeren TJ . Is apathy in late-life depressive illness related to age-at-onset, cognitive function or vascular risk? Int Psychogeriatr 2004; 16: 481–486.

    Article  PubMed  Google Scholar 

  45. Chaturvedi SK, Sarmukaddam SB . Prediction of outcome in depression by negative symptoms. Acta Psychiatr Scand 1986; 74: 183–186.

    Article  CAS  PubMed  Google Scholar 

  46. Lavretsky H, Lesser IM, Wohl M, Miller BL, Mehringer CM . Clinical and neuroradiologic features associated with chronicity in late-life depression. Am J Geriatr Psychiatry 1999; 7: 309–316.

    Article  CAS  PubMed  Google Scholar 

  47. Levkovitz Y, Sheer A, Harel EV, Katz LN, Most D, Zangen A et al. Differential effects of deep TMS of the prefrontal cortex on apathy and depression. Brain Stimul 2011; 4: 266–274.

    Article  PubMed  Google Scholar 

  48. Bonelli RM, Cummings JL . Frontal–subcortical circuitry and behavior. Dialog Clin Neurosci 2007; 9: 141–151.

    Google Scholar 

  49. Remy P, Doder M, Lees A, Turjanski N, Brooks D . Depression in Parkinson’s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005; 128 (Part 6): 1314–1322.

    Article  PubMed  Google Scholar 

  50. Chase TN . Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment. Neurotoxicity Res 2011; 19: 266–278.

    Article  Google Scholar 

  51. Alexopoulos GS, Hoptman MJ, Yuen G, Kanellopoulos D, Seirup JK, Lim KO et al. Functional connectivity in apathy of late-life depression: a preliminary study. J Affect Disord 2013; 149: 398–405.

    Article  PubMed  Google Scholar 

  52. Yuen GS, Gunning F, Woods E, Klimstra S, Hoptman MJ, Alexopoulos GS . Neuroanatomical correlates of apathy in late-life depression and antidepressant treatment response [Abstract 31]. In: American College of Neuropsychopharmacology, 51st Annual Meeting Final Program: Hollywood, FL, USA, 2012; p 206.

  53. Livingston G, Johnston K, Katona C, Paton J, Lyketsos CG . Old Age Task Force of the World Federation of Biological P. Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry 2005; 162: 1996–2021.

    Article  PubMed  Google Scholar 

  54. Verkaik R, van Weert JC, Francke AL . The effects of psychosocial methods on depressed, aggressive and apathetic behaviors of people with dementia: a systematic review. Int J Geriatr Psychiatry 2005; 20: 301–314.

    Article  PubMed  Google Scholar 

  55. Damasio AR . The somatic marker hypothesis and the possible functions of the prefrontal cortex. Philos Trans R Soc Lond Ser B 1996; 351: 1413–1420.

    Article  CAS  Google Scholar 

  56. Morris JS, Frith CD, Perrett DI, Rowland D, Young AW, Calder AJ et al. A differential neural response in the human amygdala to fearful and happy facial expressions. Nature 1996; 383: 812–815.

    CAS  PubMed  Google Scholar 

  57. Phan KL, Wager T, Taylor SF, Liberzon I . Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. NeuroImage 2002; 16: 331–348.

    Article  PubMed  Google Scholar 

  58. Etkin A, Egner T, Kalisch R . Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn Sci 2011; 15: 85–93.

    Article  PubMed  Google Scholar 

  59. Maier S, Szalkowski A, Kamphausen S, Perlov E, Feige B, Blechert J et al. Clarifying the role of the rostral dmPFC/dACC in fear/anxiety: learning. Appraisal or expression? PLoS One 2012; 7: e50120.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Mechias ML, Etkin A, Kalisch R . A meta-analysis of instructed fear studies: implications for conscious appraisal of threat. NeuroImage 2010; 49: 1760–1768.

    Article  PubMed  Google Scholar 

  61. Robinson OJ, Charney DR, Overstreet C, Vytal K, Grillon C . The adaptive threat bias in anxiety: amygdala–dorsomedial prefrontal cortex coupling and aversive amplification. NeuroImage 2012; 60: 523–529.

    Article  PubMed  Google Scholar 

  62. Mather M . The emotion paradox in the aging brain. Ann NY Acad Sci 2012; 1251: 33–49.

    Article  PubMed  Google Scholar 

  63. Roalf DR, Pruis TA, Stevens AA, Janowsky JS . More is less: emotion induced prefrontal cortex activity habituates in aging. Neurobiol Aging 2011; 32: 1634–1650.

    Article  PubMed  Google Scholar 

  64. Williams LM, Brown KJ, Palmer D, Liddell BJ, Kemp AH, Olivieri G et al. The mellow years?: neural basis of improving emotional stability over age. J Neurosci 2006; 26: 6422–6430.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Szanton SL, Wenzel J, Connolly AB, Piferi RL . Examining mindfulness-based stress reduction: perceptions from minority older adults residing in a low-income housing facility. BMC Compl Altern Med 2011; 11: 44.

    Article  Google Scholar 

  66. Howell CA, Turnbull DA, Beilby JJ, Marshall CA, Briggs N, Newbury WL . Preventing relapse of depression in primary care: a pilot study of the ‘Keeping the blues away’ program. Med J Aust 2008; 188 (Suppl): S138–S141.

    PubMed  Google Scholar 

  67. Price RB, Paul B, Schneider W, Siegle GJ . Neural correlates of three neurocognitive intervention strategies: a preliminary step towards personalized treatment for psychological disorders. Cogn Ther Res 2013; 37: 657–672.

    Article  Google Scholar 

  68. Zhang W, Li X, Liu X, Duan X, Wang D, Shen J . Distraction reduces theta synchronization in emotion regulation during adolescence. Neurosci Lett 2013; 550: 81–86.

    Article  CAS  PubMed  Google Scholar 

  69. Kendall T, McGoey L, Jackson E . If NICE was in the USA. Lancet 2009; 374: 272–273.

    Article  PubMed  Google Scholar 

  70. Morris DW, Trivedi MH . Measurement-based care for unipolar depression. Curr Psychiatry Rep 2011; 13: 446–458.

    Article  PubMed  Google Scholar 

  71. Shelton RC, Trivedi MH . Challenges and algorithm-guided treatment in major depressive disorder. J Clin Psychiatry 2011; 72: e14.

    Article  PubMed  Google Scholar 

  72. Trivedi MH . Tools and strategies for ongoing assessment of depression: a measurement-based approach to remission. J Clin Psychiatry 2009; 70 (Suppl 6): 26–31.

    Article  PubMed  Google Scholar 

  73. Trivedi MH, Rush AJ, Gaynes BN, Stewart JW, Wisniewski SR, Warden D et al. Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care. Neuropsychopharmacology 2007; 32: 2479–2489.

    Article  CAS  PubMed  Google Scholar 

  74. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163: 28–40.

    Article  PubMed  Google Scholar 

  75. Alexopoulos GS, Kiosses DN, Heo M, Murphy CF, Shanmugham B, Gunning-Dixon F . Executive dysfunction and the course of geriatric depression. Biol Psychiatry 2005; 58: 204–210.

    Article  PubMed  Google Scholar 

  76. Alexopoulos GS, Kiosses DN, Murphy C, Heo M . Executive dysfunction, heart disease burden, and remission of geriatric depression. Neuropsychopharmacology 2004; 29: 2278–2284.

    Article  PubMed  Google Scholar 

  77. Sheline YI, Pieper CF, Barch DM, Welsh-Bohmer K, McKinstry RC, MacFall JR et al. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry 2010; 67: 277–285.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Arean PA, Raue P, Mackin RS, Kanellopoulos D, McCulloch C, Alexopoulos GS . Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction. Am J Psychiatry 2010; 167: 1391–1398.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Alexopoulos GS, Raue PJ, Kiosses DN, Mackin RS, Kanellopoulos D, McCulloch C et al. Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability. Arch Gen Psychiatry 2011; 68: 33–41.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Kanter J, Mulick P, Busch A, Berlin K, Martell C . The Behavioral Activation for Depression Scale (BADS): psychometric properties and factor structure. Psychopathol Behav Assess 2007; 29: 191–202.

    Article  Google Scholar 

  81. Williams LM, Cooper NJ, Wisniewski SR, Gatt JM, Koslow SH, Kulkarni J et al. Sensitivity, specificity, and predictive power of the ‘Brief Risk-resilience Index for SCreening,’ a brief pan-diagnostic web screen for emotional health. Brain Behav 2012; 2: 576–589.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Alexopoulos GS . Depression in the elderly. Lancet 2005; 365: 1961–1970.

    Article  PubMed  Google Scholar 

  83. Institute of Medicine. The Mental Health and Substance Use Workforce for Older Adults: In Whose Hands?. Academies Press: Washington, DC, 2012.

  84. Institute of Medicine. Retooling for an Aging America: Building the Health Care Workforce. National Academies Press: Washington, DC, USA, 2008.

  85. NIMH Council Report. From Discovery to Cure: Accelerating the Development of New and Personalized Interventions for Mental Illnesses 2010; http://www.nimh.nih.gov/about/advisory-boards-and-groups/namhc/reports/fromdiscoverytocure.pdf.

  86. NIMH Council Report. Bridging Science and Service 1998; http://www.apps.nimh.nih.gov/ecb/archives/nimhbridge.pdf.

  87. Centers for Disease Control and Prevention. National Center for Injury Prevention and Control. Web-based Injury Statistics Query and Reporting System (WISQARS) 2010; http://www.cdc.gov/injury/wisqars/index.html.

Download references

Acknowledgements

This paper was supported by P30 MH085943 (to GSA), MH074717 (to PA), MH075900 (to PA) and MH077192 (to PA).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G S Alexopoulos.

Ethics declarations

Competing interests

Dr Alexopoulos had a research grant from Forest; consulted to Pfizer and Otsuka; and serves on the speaker’s bureaus of Astra Zeneca, Avanir, Novartis and Sunovion. Dr Arean reports no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Molecular Psychiatry website

Supplementary information

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alexopoulos, G., Arean, P. A model for streamlining psychotherapy in the RDoC era: the example of ‘Engage’. Mol Psychiatry 19, 14–19 (2014). https://doi.org/10.1038/mp.2013.150

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2013.150

Keywords

This article is cited by

Search

Quick links